Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
11/21/2022 | 85.19% | Lake Street | → $3 | Assumes | → Buy |
05/20/2022 | 85.19% | Lake Street | → $3 | Initiates Coverage On | → Buy |
What is the target price for Streamline Health Solns (STRM)?
The latest price target for Streamline Health Solns (NASDAQ: STRM) was reported by Lake Street on November 21, 2022. The analyst firm set a price target for $3.00 expecting STRM to rise to within 12 months (a possible 85.19% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Streamline Health Solns (STRM)?
The latest analyst rating for Streamline Health Solns (NASDAQ: STRM) was provided by Lake Street, and Streamline Health Solns their buy rating.
When is the next analyst rating going to be posted or updated for Streamline Health Solns (STRM)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Streamline Health Solns, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Streamline Health Solns was filed on November 21, 2022 so you should expect the next rating to be made available sometime around November 21, 2023.
Is the Analyst Rating Streamline Health Solns (STRM) correct?
While ratings are subjective and will change, the latest Streamline Health Solns (STRM) rating was a with a price target of $0.00 to $3.00. The current price Streamline Health Solns (STRM) is trading at is $1.62, which is within the analyst's predicted range.